🔎 Trials Near Me

Home › Atake sa Puso › Tennessee

Pag-aaral pangklinika para sa Atake sa Puso sa Tennessee

5 pag-aaral para sa Atake sa Puso ang naghahanap ng mga kalahok sa mga site sa Tennessee.

Mga Lungsod sa Tennessee

Opisyal na teksto ng pag-aaral (English)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Southeast Renal Research Institute, Chattanooga
  • Dialysis Clinic Inc - University Nephology, Knoxville
  • Knoxville Kidney Center PLLC, Knoxville
  • at 2 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • The Stern Cardiovascular Foundation, Germantown
  • Apex Cardiology Research Associates of Jackson, Jackson
  • Vanderbilt Univ Medi Cen, Nashville
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Erlanger Health, Inc., Chattanooga
  • Ascension Saint Thomas, Nashville
  • Parkway Cardiology Associates, Oak Ridge
  • at 1 pa
Nagre-recruitPhase 3
Edad 50 hanggang 105 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07136012

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  • Vanderbilt University Medical Center, Nashville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04774159

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

  • University of Tennessee Medical Center, Knoxville
  • University of Tennessee Health Science Center/Regional One Health, Memphis
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 29, 2026 · NCT06374277

Mula sa ClinicalTrials.gov, na-kuha noong Okt 3, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.